---
title: "Assura (LON:AGR) Trading 14.3% Higher   - Here's What Happened"
description: "Assura Plc's stock surged 14.3% on Monday, reaching a high of GBX 46.86 ($0.60) before closing at GBX 46.56 ($0.60). Trading volume increased by 256% to 78,156,086 shares. The company has a market cap"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/231472074.md"
published_at: "2025-03-12T04:32:32.000Z"
---

# Assura (LON:AGR) Trading 14.3% Higher   - Here's What Happened

> Assura Plc's stock surged 14.3% on Monday, reaching a high of GBX 46.86 ($0.60) before closing at GBX 46.56 ($0.60). Trading volume increased by 256% to 78,156,086 shares. The company has a market cap of £1.52 billion and a debt-to-equity ratio of 85.05. Assura, a healthcare property investor, operates over 600 healthcare buildings in the UK and Ireland and achieved B Corp certification in July 2024, becoming the first FTSE 250 company to do so.

Assura Plc (LON:AGR - Get Free Report)'s stock price shot up 14.3% on Monday . The company traded as high as GBX 46.86 ($0.60) and last traded at GBX 46.56 ($0.60). 78,156,086 shares changed hands during mid-day trading, an increase of 256% from the average session volume of 21,937,410 shares. The stock had previously closed at GBX 40.74 ($0.52).

## Assura Trading Up 14.3 %

The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The stock's 50-day moving average is GBX 38.87 and its two-hundred day moving average is GBX 39.81. The company has a market cap of £1.52 billion, a P/E ratio of -44.51, a P/E/G ratio of 3.60 and a beta of 0.37.

## About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

## See Also

-   Five stocks we like better than Assura
-   Consumer Staples Stocks, Explained
-   How to Protect Your Portfolio When Inflation Is Rising
-   Procter & Gamble NYSE: PG Pulls Back After Shaky Guidance
-   3 Tech Stocks Defying Sector Weakness and Thriving in 2025
-   REIT Stocks - Best REIT Stocks to Add to Your Portfolio Today
-   Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

*This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.*

## Should You Invest $1,000 in Assura Right Now?

Before you consider Assura, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.

While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [AGR.UK - Assura PLC](https://longbridge.com/en/quote/AGR.UK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 格林布赖尔公司（GBX）的牛市前景可能会因利润率和现金流压力而发生变化 - 了解其中原因 | 格林布赖尔公司（Greenbrier Companies，GBX）面临单位销售下降、毛利率低于同行 14% 以及自由现金流短缺等挑战，这引发了对其运营模式的担忧。该公司的投资叙述依赖于其在这些压力下将积压订单和租赁收入转化为收益的能力。最近 | [Link](https://longbridge.com/en/news/276366779.md) |
| 美股盘中速递：医疗保健行业波动加剧，Dermata Therapeutics 股价暴跌 24.87%！分析师评级引发市场担忧 | Dermata Therapeutics 跌 24.87%；GRAIL 跌 45.71%，成交额达到 4.01 亿美元；艾伯维跌 0.22%，成交额达到 2.75 亿美元；安进跌 0.28%，成交额达到 2.18 亿美元；吉利德科学涨 0. | [Link](https://longbridge.com/en/news/276461704.md) |
| 14:54 ET 患者安全运动基金会全球峰会将通过 Coresee 进行全球直播 | 患者安全运动基金会（PSMF）宣布，其全球峰会将通过 Coresee 进行全球直播，全球参与费用为 100 美元。此次峰会旨在应对患者安全危机，讨论包括医疗保健中的人工智能和母婴死亡率等主题。主要医疗保健领导者将分享改善患者安全的承诺，强调 | [Link](https://longbridge.com/en/news/276481011.md) |
| 双威医疗保健委任六家投行担任上市承销商 \| 联合早报网 | 双威医疗保健（Sunway Healthcare）已委任六家投资银行作为首次公开售股（IPO）的承销商，计划在马来西亚上市，预计集资超过 30 亿令吉，估值将超过 150 亿令吉。承销商包括马来亚、艾芬黄氏、联昌国际、兴业、肯纳格及大马投资 | [Link](https://longbridge.com/en/news/275451558.md) |
| Anastassis David 出售了 2,991 股 Coca-Cola HBC（LON:CCH）的股票 | 可口可乐 HBC AG 的内部人士 Anastassis David 于 2 月 11 日出售了 2,991 股公司股票，总金额为 140,965.83 英镑，平均价格为 GBX 4,713。目前该股票交易下跌 0.4%，报 GBX 4,7 | [Link](https://longbridge.com/en/news/275967500.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
